Structure-activity relationship of the ring portion in backbone-cyclic C-terminal hexapeptide analogs of substance P - NMR and molecular dynamics

被引：0
|
作者：
Behrens, S
Matha, B
Bitan, G
Gilon, C
Kessler, H
机构：
[1] TECH UNIV MUNICH,INST ORGAN CHEM & BIOCHEM,LEHRSTUHL 2,D-85747 GARCHING,GERMANY
[2] HEBREW UNIV JERUSALEM,DEPT ORGAN CHEM,JERUSALEM,ISRAEL
来源：
INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH | 1996年 / 48卷 / 06期
关键词：
backbone cyclization; conformational analysis; molecular dynamics; NMR spectroscopy; substance P;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The conformations of two backbone-cyclized substance P analogs were derived from homo- and heteronuclear NMR measurements and molecular dynamics simulations carried out in DMSO. The analogs contain subtle variations in the ring chemistry and are compared with biologically active analogs previously examined. The correlation between conformation and activity is used to gain insight into the conformational requirements from the pharmacophore. (C) Munksgaard 1996.
引用
收藏
页码：569 / 579
页数：11
相关论文
共 50 条
  • [41] Peptide-based inhibitors of the hepatitis C virus NS3 protease:: Structure-activity relationship at the C-terminal position
    Rancourt, J
    Cameron, DR
    Gorys, V
    Lamarre, D
    Poirier, M
    Thibeault, D
    Llinàs-Brunet, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) : 2511 - 2522
  • [42] Modeling the Relationship between the p53 C-Terminal Domain and Its Binding Partners Using Molecular Dynamics
    Allen, William J.
    Capelluto, Daniel G. S.
    Finkielsein, Carla V.
    Bevan, David R.
    JOURNAL OF PHYSICAL CHEMISTRY B, 2010, 114 (41): : 13201 - 13213
  • [43] A detailed structure-activity relationship (SAR) study of the bioactive N-terminal metabolite SP1-7 of substance P
    Fransson, R.
    Sandstrom, A.
    Botros, M.
    Nyberg, F.
    Hallberg, M.
    Lindeberg, G.
    BIOPOLYMERS, 2007, 88 (04) : 589 - 589
  • [44] Cyclic HIV protease inhibitors: Synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas
    Lam, PYS
    Ru, Y
    Jadhav, PK
    Aldrich, PE
    DeLucca, GV
    Eyermann, CJ
    Chang, CH
    Emmett, G
    Holler, ER
    Daneker, WF
    Li, LZ
    Confalone, PN
    McHugh, RJ
    Han, Q
    Li, RH
    Markwalder, JA
    Seitz, SP
    Sharpe, TR
    Bacheler, LT
    Rayner, MM
    Klabe, RM
    Shum, LY
    Winslow, DL
    Kornhauser, DM
    Jackson, DA
    EricksonViitanen, S
    Hodge, CN
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (18) : 3514 - 3525
  • [45] EFFECT OF SUBSTITUTION OF GLYCINE BY D-ALANINE OR L-ALANINE ON THE ACTIVITY OF THE C-TERMINAL HEXAPEPTIDE ANALOG OF SUBSTANCE-P ON ISOLATED GUINEA-PIG ILEUM
    LIPKOWSKI, AW
    DRABAREK, S
    MAJEWSKI, T
    KONECKA, AM
    SADOWSKI, B
    EXPERIENTIA, 1981, 37 (05): : 499 - 500
  • [46] A Two-Step Strategy for Structure-Activity Relationship Studies of N-Methylated Aß42 C-Terminal Fragments as Aß42 Toxicity Inhibitors
    Li, Huiyuan
    Zemel, Reeve
    Lopes, Dahabada H. J.
    Monien, Bernhard H.
    Bitan, Gal
    CHEMMEDCHEM, 2012, 7 (03) : 515 - 522
  • [47] A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are δ/μ opioid receptor agonists and neurokinin 1 receptor antagonists
    Yamamoto, Takashi
    Nair, Padma
    Vagner, Josef
    Largent-Milnes, Tally
    Davis, Peg
    Ma, Shou-wu
    Navratilova, Edita
    Moye, Sharif
    Tumati, Suneeta
    Lai, Josephine
    Yamamura, Henry I.
    Vanderah, Todd W.
    Porreca, Frank
    Hruby, Victor J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) : 1369 - 1376
  • [48] Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors
    Mermerian, Ara H.
    Case, April
    Stein, Ross L.
    Cuny, Gregory D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (13) : 3729 - 3732
  • [49] A structure-activity relationship study on position-2 of the Gαs C-terminal peptide able to inhibit Gs activation by A2A adenosine receptor
    Grieco, P
    Albrizio, S
    D'Ursi, AM
    Giusti, L
    Mazzoni, MR
    Novellino, E
    Rovero, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (01) : 13 - 18
  • [50] The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations
    Fadda, E.
    Nixon, M. G.
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2017, 19 (32) : 21287 - 21296
12345